Hofseth BioCare ASA reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was NOK 118.89 million compared to NOK 76.88 million a year ago. Revenue was NOK 120.45 million compared to NOK 87.62 million a year ago.

Net loss was NOK 137.13 million compared to NOK 126.46 million a year ago. Basic loss per share from continuing operations was NOK 0.37 compared to NOK 0.35 a year ago. Diluted loss per share from continuing operations was NOK 0.37 compared to NOK 0.35 a year ago.